Novo Nordisk Sees More Competition in U.S. Drug Prices

Lars Fruergaard Jorgensen, chief executive officer at Novo Nordisk, discusses drug affordability, price caps and his strategy for growth. He speaks on "Bloomberg Markets: European Open." (Source: Bloomberg)

Quilvest Says Investors Will Reduce Risk Short-Term
32:52 - Bob Parker, member of the investment committee at Quilvest Investment Management, discusses geopolitical risk and its impact on markets. He speaks on "Bloomberg Daybreak: Europe." (Source: Bloomberg)
  • Control Risks' Donald Expected an Attack in Europe
  • Independent Strategy Says N. Korea Will Not Give Up
  • Gatecoin Sees Bitcoin at 5,000 by Year End